Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Feb 2023
Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.
Read Full NewsA trio of neurology experts discussed the clinical application of the 2025 updated multiple sclerosis diagnostic criteria, including imaging and biomarker tools, to support patient care.
A look back at clinician-led features from 2025 that examine the questions, data, and decisions shaping neurologic care.
Q1 2026 Preview: 5 FDA Decisions to Watch in Specialty Care
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
3.
When a Groundbreaking Cancer Therapy Causes Cancer.
4.
Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.
5.
Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer
1.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
2.
The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review
3.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
4.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
5.
Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Thromboprophylaxis In Medical Settings
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge